Company intelligence / Profile preview
Shanghai RAAS
Shanghai, Shanghai, Chinaraas-corp.com ↗
- Ownership
- Private
- Employees
- ~3350
- Development stage
- Other
01
Overview
Shanghai RAAS is a leading Chinese manufacturer of plasma-derived blood products. Its portfolio includes human albumin for hypoalbuminemia and critical care; immunoglobulins for immune deficiencies and infectious disease prophylaxis; coagulation factors for hemophilia and bleeding disorders; as well as specialty products like fibrin sealant. The company has extensive manufacturing capabilities and exports to Southeast Asia and Latin America[1][3][4].
- Therapeutic areas
- GastroenterologyHematologyImmunologyInfectious Diseases
- Modalities
- BiologicProtein
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Boehringer-Ingelheim
Beyond the preview
Go deeper on Shanghai RAAS.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai RAAS.